---
title: "NAFLD"
description: "NAFLD (fatty liver) is common in Indian GLP-1 candidates and may improve with weight loss on therapy."
canonical: "https://www.kesho.health/glossary/nafld"
markdown_url: "https://www.kesho.health/md/glossary/nafld"
language: "en-IN"
---

# NAFLD

**Canonical HTML:** https://www.kesho.health/glossary/nafld  
**Markdown:** https://www.kesho.health/md/glossary/nafld

## Definition

NAFLD (non-alcoholic fatty liver disease) is excess fat in the liver unrelated to alcohol, linked to obesity and insulin resistance.

## Extended

Weight loss of 5–10% on GLP-1 therapy can reduce hepatic steatosis. Alcohol should be minimised. Common comorbidity supporting earlier obesity pharmacotherapy in India. In India, these concepts appear in RSSDI and ICMR guidance for type 2 diabetes and obesity care—always confirm details with your prescribing physician.

## Learn more

[Full guide](https://www.kesho.health/blog/glp-1-and-alcohol-india) · [MD](https://www.kesho.health/md/blog/glp-1-and-alcohol-india)

## Related terms

- [obesity](https://www.kesho.health/glossary/obesity)
- [type-2-diabetes](https://www.kesho.health/glossary/type-2-diabetes)
- [thin-fat-phenotype](https://www.kesho.health/glossary/thin-fat-phenotype)